click below
click below
Normal Size Small Size show me how
Pharmacology CH 1,2
medications
Question | Answer |
---|---|
Three types of drug sources | 1. natural plants ex opium purple fox glove 2. chemical synthesis 3 genetic egineering |
5 drug classifications | theurapuetic- what it does physiological how it does body system where it works prescription or otc Chemical type barbituates, dermatologic |
pharmacokinetics | physiologic processing of drugs |
how does the body process drugs | liver->metabolizes the kidneys excrete |
pharmacodynamics | physiological response to drug |
agonist | effect produced |
antagonist | effect blocked |
synergists | effect enhanced |
indicated and contraindicated | indicated means should be given contraindicated means should not be give maybe allergy |
hypersensitivity | produced from previous taking of the drug |
idiosyncrasy | unpredicable and is unique to you genetic |
duration | the time between the drug from time of onset til disappearance |
onset | from administration til effects seen |
parenteral | given injected |
bolus | given all at once throuugh iv |
reconsitited | mixed |
orders that can be given in or | standing verbal stat by surgeons preference card |
prn | given as needed but with a limit |
3 characteristics of side effect | unpredicatable expected unavoidable mild |
FDA | food and drug administration ensures quality of drugs and safety |
DEA | drug enforcement agency regulates controlled subtances |
Class 1 | high abuse no medical use marijuana, lsd, and herion |
Class 2 | high abuse approved meds codeine,morphine, fentanyl, opium, cocaine |
Class 3 | moderate abuse approved anabolic steriods, limeted codiene preps like tylenol 3 |
Class 4 | limited abuse barbituates |
Class 5 | low abuse minimal risks antitussives, antidiarrheals, limited narcotic |
Osha | protects workers and sharp standards |
CDC | promotes public safety and health writes sharps protocol for injuries |
Testing | 2 species both genders before humans |
3 clinical testings | 1. clinical pharmacology group of 18-45 dose that is toxix, 2. clinical investigation determines dose few people 3 clinical trials before marketing |
pharmacogenetics | STUDY OF GENETIC INFLUENCE ON DURG ACTION |
PHARMACOGENOMICS | STUDY OF GENES THAT DETERMINE THE RESPONSE TO MEDS |